Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the Lung
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00511290|
Recruitment Status : Completed
First Posted : August 3, 2007
Last Update Posted : August 3, 2007
In the present study inflammatory mediators will be isolated in induced sputum and exhaled breath condensate and will be correlated with particulate matter measured in these samples.Particulate matter will be assessed by partcle size distribution method and shape analysis.
The aim of the study is to perform biological monitoring in environmental and occupational diseases in a non invassive fashion.
|Condition or disease||Intervention/treatment|
|Asthma Chronic Obstructive Pulmonary Disease Interstitial Lung Diseases Occupational Lung Diseases||Other: no generic names|
|Study Type :||Observational|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00511290
|Tel-Aviv Sourasky Medical Center|
|Tel-Aviv, Israel, 64239|
|Principal Investigator:||Fireman Lizy, PhD||Tel Aviv University|